Variant report
Variant | esv3386680 |
---|---|
Chromosome Location | chr5:127903453-127907351 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182279392 | chr5:127903476-127903477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537764662 | chr5:127903489-127903490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35372786 | chr5:127903492-127903493 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs144595281 | chr5:127903547-127903548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549715892 | chr5:127903567-127903568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569560470 | chr5:127903572-127903573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6595842 | chr5:127903628-127903629 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs186602195 | chr5:127903629-127903630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371109501 | chr5:127903680-127903681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs80254117 | chr5:127903687-127903688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192345880 | chr5:127903689-127903690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183907383 | chr5:127903799-127903800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138540730 | chr5:127903823-127903824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538489352 | chr5:127903839-127903840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555151017 | chr5:127903880-127903881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537351534 | chr5:127903947-127903948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557274333 | chr5:127903957-127903958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571898412 | chr5:127904019-127904020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74414560 | chr5:127904112-127904113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115611364 | chr5:127904191-127904192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114895196 | chr5:127904199-127904200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78829416 | chr5:127904236-127904237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553487702 | chr5:127904270-127904271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573401421 | chr5:127904280-127904281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs71575723 | chr5:127904295-127904296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71575724 | chr5:127904380-127904381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371145363 | chr5:127904402-127904403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541192865 | chr5:127904439-127904440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558016640 | chr5:127904451-127904452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564142704 | chr5:127904492-127904493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188872949 | chr5:127904500-127904501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs13179503 | chr5:127904508-127904509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374206176 | chr5:127904523-127904524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573661035 | chr5:127904527-127904528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71587984 | chr5:127904533-127904534 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs12652442 | chr5:127904546-127904547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563291773 | chr5:127904568-127904569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs13179535 | chr5:127904574-127904575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528852220 | chr5:127904591-127904592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532181175 | chr5:127904606-127904607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115710100 | chr5:127904693-127904694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528186612 | chr5:127904699-127904700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551909864 | chr5:127904710-127904711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12233934 | chr5:127904725-127904726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571748723 | chr5:127904736-127904737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62390696 | chr5:127904738-127904739 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs374108851 | chr5:127904751-127904752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184463486 | chr5:127904773-127904774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536625683 | chr5:127904854-127904855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368324144 | chr5:127904859-127904860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:127901400-127904000 | Enhancers | Placenta | Placenta |
2 | chr5:127901600-127903600 | Enhancers | Hela-S3 | cervix |
3 | chr5:127902600-127903600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr5:127902600-127907200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr5:127902600-127907400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr5:127902800-127907800 | Weak transcription | A549 | lung |
7 | chr5:127903200-127903800 | Enhancers | Placenta Amnion | Placenta Amnion |
8 | chr5:127903400-127904200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr5:127903600-127904200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr5:127903600-127904200 | Enhancers | NHEK | skin |
11 | chr5:127903800-127908800 | Weak transcription | Placenta Amnion | Placenta Amnion |
12 | chr5:127904000-127908800 | Weak transcription | Placenta | Placenta |
13 | chr5:127904200-127907200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr5:127904200-127907800 | Weak transcription | NHEK | skin |
15 | chr5:127905400-127906400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr5:127905800-127906200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr5:127905800-127906200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr5:127907200-127907600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
19 | chr5:127907200-127910600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |